Want to see NZ:SCL full AI Analyst Report?
SCL Stock Chart & Stats
$6.55
$0.15(2.34%)
―
--
Day’s Range― - ―
52-Week Range$5.59 - $7.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)180.54K
Market Cap
$960.09M
Enterprise Value$1.17B
Total Cash (Recent Filing)$51.09M
Total Debt (Recent Filing)$274.35M
Price to Earnings (P/E)11.3
Beta0.91
Next Earnings
Feb 24, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.25%
Share Statistics
EPS (TTM)0.58
Shares Outstanding146,579,150
10 Day Avg. Volume104,249
30 Day Avg. Volume180,543
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.92
Price to Sales (P/S)0.93
P/FCF Ratio11.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.41
Revenue Forecast (FY)$1.44B
Bulls Say, Bears Say
Bulls Say
Broad-based 2026 Earnings GrowthBroad-based growth across all three operating divisions reduces reliance on a single business line and indicates stronger underlying demand, volume and portfolio contributions. The upgraded full-year guidance also supports confidence that improved earnings can extend beyond one isolated reporting period.
Improved Revenue And ProfitabilityThe sharp improvement in revenue and operating profitability demonstrates meaningful earnings recovery and stronger operating leverage. If the higher activity levels and improved mix persist, Scales should have greater internal capacity to reinvest, support its subsidiaries and build earnings over coming quarters.
European Petfood ExpansionTaking full control of Esro Petfood increases Scales’ exposure to European growth and gives management complete authority over operating improvements, regional supply and demand development. The transaction broadens the Global Proteins platform and creates scope for more integrated execution.
Bears Say
Materially Higher LeverageThe substantial increase in leverage reduces financial flexibility compared with Scales’ more conservatively financed 2021–2024 period. Higher debt can constrain future capital allocation and make the business more sensitive to weaker operating performance, especially while expanding through acquisitions.
Weak Operating Cash ConversionWeak conversion of accounting profit into operating cash raises questions about the timing and quality of earnings, even though free cash flow remained positive. If the shortfall persists, working-capital needs could pressure liquidity and reduce funds available for investment or debt reduction.
Volatile Profit QualityLarge year-to-year swings in margins and profit make future earnings less predictable and weaken confidence that the 2025 improvement is fully sustainable. Inconsistent gross margins suggest business mix or one-off effects may continue to influence results and complicate planning.
Scales Corp. Ltd. News
SCL FAQ
What was Scales Corp. Ltd.’s price range in the past 12 months?
Scales Corp. Ltd. lowest stock price was $5.59 and its highest was $7.50 in the past 12 months.
What is Scales Corp. Ltd.’s market cap?
Scales Corp. Ltd.’s market cap is $960.09M.
When is Scales Corp. Ltd.’s upcoming earnings report date?
Scales Corp. Ltd.’s upcoming earnings report date is Feb 24, 2027 which is in 116 days.
How were Scales Corp. Ltd.’s earnings last quarter?
Scales Corp. Ltd. released its earnings results on Aug 26, 2026. The company reported $0.362 earnings per share for the quarter, beating the consensus estimate of $0.329 by $0.033.
Is Scales Corp. Ltd. overvalued?
According to Wall Street analysts Scales Corp. Ltd.’s price is currently Undervalued.
Does Scales Corp. Ltd. pay dividends?
Scales Corp. Ltd. pays a Notavailable dividend of $0.136 which represents an annual dividend yield of 4.25%. See more information on Scales Corp. Ltd. dividends here
What is Scales Corp. Ltd.’s EPS estimate?
Scales Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scales Corp. Ltd. have?
Scales Corp. Ltd. has 146,579,150 shares outstanding.
What happened to Scales Corp. Ltd.’s price movement after its last earnings report?
Scales Corp. Ltd. reported an EPS of $0.362 in its last earnings report, beating expectations of $0.329. Following the earnings report the stock price went up 5.425%.
Which hedge fund is a major shareholder of Scales Corp. Ltd.?
Currently, no hedge funds are holding shares in NZ:SCL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Scales Corp. Ltd.
Scales Corporation Limited engages in manufacturing and trading of food ingredients in New Zealand, Asia, Europe, North America, and internationally. It operates through Global Proteins, Horticulture, Logistics, and Other segments. The company processes and markets proteins, such as pet food ingredients, edible meat, and offal products; and orchards, fruit packing, and juice concentrate. In addition, it provides sea and air freight, and logistics services. Further, the company provides insurance services; and operates cold storage. Scales Corporation Limited was founded in 1897 and is based in Christchurch, New Zealand.
Technical Analysis
a2 Milk Company
―
Seeka Limited
―
Delegat Group Limited
―
Fonterra Co-operative Group Limited
―
T&G Global Limited
―